Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
https://link.springer.com/content/pdf/10.1208/s12248-008-9041-8.pdf
Reference48 articles.
1. I. Kola, and J. Landis. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3(8):711–5 (2004).
2. B. H. Littman, and S. A. Williams. The ultimate model organism: progress in experimental medicine. Nature Rev. Drug Discov. 4(8):631–8 (2005).
3. R. Krishna. Introduction to dose optimization. In R. Krishna (ed.), Dose optimization in drug development, Taylor and Francis, v161, 2006, pp. 1–13.
4. R. Krishna. Quantitative clinical pharmacology: making paradigm shifts a reality. J. Clin. Pharmacol. 46(9):966–7 (2006).
5. C. -P. Milne. US and European regulatory initiatives to improve R&D performance. Expert Opinion on Drug Discovery. 1(1):11–4 (2006).
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors from Coptis chinensis Using Virtual Screening, Bioactivity Evaluation, and Binding Studies;Molecules;2024-05-14
2. Animal Models: Practical Use and Considerations;The Handbook of Medicinal Chemistry;2023-02-03
3. A double‐blind, randomized, placebo and positive‐controlled study in healthy volunteers to evaluate pharmacokinetic and pharmacodynamic properties of multiple oral doses of cetagliptin;British Journal of Clinical Pharmacology;2022-02-04
4. In Vivo Profiling with 18F-YJH08 Reveals Diverse Tissue Patterns of Antagonist/Glucocorticoid Receptor Interactions;Molecular Pharmaceutics;2022-01-20
5. Identification of a Human Whole Blood–Based Endothelial Cell Impedance Assay for Assessing Clinical Transient Receptor Potential Vanilloid 4 Target Engagement Ex Vivo;Journal of Pharmacology and Experimental Therapeutics;2020-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3